Covered recipient · General Payments record
SHYALL BHELA
Allopathic & Osteopathic Physicians Pediatrics Pediatric Pulmonology
General Payments · PY2022–2025
$731.54
- Reported across 30 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $229.24 | 10 |
| Education | $100.00 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $132.60 | 6 |
| Carl Zeiss Meditec USA, Inc. | $100.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $29.82 | 1 |
| BAXTER HEALTHCARE | $27.85 | 1 |
| Amgen Inc. | $21.75 | 1 |
| Acerta Pharma LLC | $17.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $21.75 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228575389 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.22 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207095295 | CMS |
| Baxter Healthcare | $27.85 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181606384 | CMS |
| Carl Zeiss Meditec USA, Inc. | $100.00 | 10/13/2025 | Education | Undisputed | 06/30/2026 | 1249358334 | CMS |
| GlaxoSmithKline, LLC. | $30.03 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191367444 | CMS |
| GlaxoSmithKline, LLC. | $15.56 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190613026 | CMS |
| GlaxoSmithKline, LLC. | $14.43 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191836179 | CMS |
| GlaxoSmithKline, LLC. | $26.21 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190767270 | CMS |
| GlaxoSmithKline, LLC. | $18.85 | 07/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190969642 | CMS |
| GlaxoSmithKline, LLC. | $27.52 | 09/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190627966 | CMS |
| Novartis Pharmaceuticals Corporation | $29.82 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200163083 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.